lactic acid has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 7 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, B | 1 |
| Pomicter, AD | 1 |
| Li, F | 1 |
| Bhatt, S | 1 |
| Chen, C | 1 |
| Li, W | 1 |
| Qi, M | 1 |
| Huang, C | 1 |
| Deininger, MW | 1 |
| Kong, MG | 1 |
| Chen, HL | 1 |
| Gayatri, MB | 1 |
| Kancha, RK | 1 |
| Patchva, D | 1 |
| Velugonda, N | 1 |
| Gundeti, S | 1 |
| Reddy, ABM | 1 |
| De Rosa, V | 1 |
| Monti, M | 1 |
| Terlizzi, C | 1 |
| Fonti, R | 1 |
| Del Vecchio, S | 1 |
| Iommelli, F | 1 |
| Gavrilov, K | 1 |
| Seo, YE | 1 |
| Tietjen, GT | 1 |
| Cui, J | 1 |
| Cheng, CJ | 1 |
| Saltzman, WM | 1 |
| Klawitter, J | 2 |
| Kominsky, DJ | 1 |
| Brown, JL | 1 |
| Christians, U | 1 |
| Leibfritz, D | 1 |
| Melo, JV | 1 |
| Eckhardt, SG | 1 |
| Serkova, NJ | 1 |
| Acharya, S | 1 |
| Sahoo, SK | 1 |
| SANTAGATI, U | 1 |
| BOLDRINI, R | 1 |
7 other studies available for lactic acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Humans; Lactic Acid; Leukemia, Experimental; Leukemia, My | 2021 |
Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia.
Topics: Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Glucose; Humans; Ima | 2023 |
Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells.
Topics: Antineoplastic Agents; Caspase 3; Cell Line, Tumor; Cyclin D1; Glycolysis; Humans; Imatinib Mesylate | 2019 |
Enhancing potency of siRNA targeting fusion genes by optimization outside of target sequence.
Topics: Apoptosis; Base Sequence; Binding Sites; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Fus | 2015 |
Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Cell Line, Tumor; Cell Proliferatio | 2009 |
Sustained targeting of Bcr-Abl + leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferatio | 2011 |
[Behavior of sugar, pyruvic acid and lactic acid in blood in lymphadenosis and chronic myeloid leukemia].
Topics: Blood Glucose; Humans; Lactic Acid; Leukemia; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BC | 1955 |